Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Arceci

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
The British Journal of Cancer. Supplement|September 1, 1994
Treatment options--commentaryR J Arceci
Current Opinion in Hematology|July 1, 1996
Tumor cell survival and resistance to therapyR J Arceci
Current Opinion in Hematology|July 1, 1995
Mechanisms of resistance to therapy and tumor cell survivalR J Arceci
Journal of Molecular Medicine (Berlin, Germany)|March 21, 1998
The potential for antitumor vaccination in acute myelogenous leukemiaR J Arceci
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1977
Noncoincidence of histone and DNA synthesis in cleavage cycles of early developmentR J Arceci, P R Gross
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistanceD M Bradshaw, R J Arceci
Science (New York, N.Y.)|August 1, 1980
Histone gene expression: progeny of isolated early blastomeres in culture make the same change as in the embryoR J Arceci, P R Gross
Leukemia & Lymphoma|May 30, 2001
Activating mutations of c-kit at codon 816 confer drug resistance in human leukemia cellsZ Q Ning, J Li, R J Arceci
Blood|May 23, 2001
Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cellsZ Q Ning, J Li, R J Arceci
Developmental Biology|May 1, 1992
Expression of CSF-1/c-fms and SF/c-kit mRNA during preimplantation mouse developmentR J Arceci, S Pampfer, J W Pollard
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
The British Journal of Cancer. Supplement|September 1, 1994
Treatment options--commentaryR J Arceci
Current Opinion in Hematology|July 1, 1996
Tumor cell survival and resistance to therapyR J Arceci
Current Opinion in Hematology|July 1, 1995
Mechanisms of resistance to therapy and tumor cell survivalR J Arceci
Journal of Molecular Medicine (Berlin, Germany)|March 21, 1998
The potential for antitumor vaccination in acute myelogenous leukemiaR J Arceci
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1977
Noncoincidence of histone and DNA synthesis in cleavage cycles of early developmentR J Arceci, P R Gross
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistanceD M Bradshaw, R J Arceci
Science (New York, N.Y.)|August 1, 1980
Histone gene expression: progeny of isolated early blastomeres in culture make the same change as in the embryoR J Arceci, P R Gross
Leukemia & Lymphoma|May 30, 2001
Activating mutations of c-kit at codon 816 confer drug resistance in human leukemia cellsZ Q Ning, J Li, R J Arceci
Blood|May 23, 2001
Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cellsZ Q Ning, J Li, R J Arceci
Developmental Biology|May 1, 1992
Expression of CSF-1/c-fms and SF/c-kit mRNA during preimplantation mouse developmentR J Arceci, S Pampfer, J W Pollard
Pageof 6